Clinically significant drug interactions with antidepressants in the elderly.
about
Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individualsAntidepressants relevant to oral and maxillofacial surgical practiceEffects of music on depression in older people: a randomised controlled trial.Influence of sex and stress exposure across the lifespan on endophenotypes of depression: focus on behavior, glucocorticoids, and hippocampus.Safety of antidepressants in the elderly.The safety of SSRIs in generalised anxiety disorder: any reason to be anxious?Pre-injury polypharmacy as a predictor of outcomes in trauma patients.Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status.Safety and side effect profile of fluoxetine.Pharmacogenomics, informatics, and individual drug therapy in psychiatry: past, present and future.Systematic overview of drug interactions with antidepressant medications.The pharmacogenetics of analgesia.Physical activity in depressed elderly. A systematic review.Use of drugs that act on the cytochrome P450 system in the elderly.Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region.Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review.Pharmacogenetic considerations for late life depression therapy.Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety.Pharmacokinetic interaction between fluoxetine and omeprazole in healthy male volunteers: a prospective pilot study.Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult psychiatric and functional elderly psychiatric wards.Effects of calcium channel blockers on antidepressant action of Alprazolam and Imipramine.Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly.Effect of fluoxetine on the pharmacokinetics of lansoprazole: a two-treatment period study in healthy male subjects.Effects of fluvoxamine on lansoprazole pharmacokinetics in relation to CYP2C19 genotypes.Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions.Mixed anxiety and depression in older adults: clinical characteristics and management.Venlafaxine-associated serotonin syndrome and manic episode in a geriatric depressive patient.Utilization of antidepressants in Taiwan: a nationwide population-based survey from 2000 to 2009.Depressive symptoms among frail elderly in ordinary living: who is affected and who is treated?Clinical pharmacy in a multidisciplinar team for chronic pain in adults.
P2860
Q24815657-029A313E-73CB-41CB-A028-342004DFA169Q26852531-1A0351F7-B29D-48A2-B5E3-382AA5D3F0ADQ30408710-7EB0A025-4C1E-40A4-96A6-4ADE8FF1BDC5Q34840916-43938285-B612-4393-AC19-5DCA885F5FF5Q35194349-223F1DBE-33E0-46A8-8861-950CA5EAADF5Q35208413-46A925EC-C386-48BA-BFB6-E2D9B16EC4B5Q35646574-76A15849-B604-4B78-B0A1-88DCDF6711A7Q35827487-7238B443-E01F-4A06-B2B1-8C49D10D8B85Q35873740-B4408835-CA5F-4EE2-9355-361709E5089EQ36511706-311A6816-E4C2-4569-A7B9-98E0C3CEFD0BQ36598763-7609D706-42C2-46FD-A671-21E8992BDE68Q36967259-B469AD42-00C7-4101-9162-26E35241FA8EQ37136799-E9035177-6DB8-48C9-8998-2149FB7D5C7BQ37222734-39ECD597-58AB-4D40-9284-B10356FA0048Q37761937-216D82C1-4BE3-42EE-8C88-113864E1371EQ37981714-26360780-1D63-41E3-A8D1-6FBF7D8E0453Q38103882-E5D9A9CF-7399-41F3-9D8C-49F4116DBA6CQ38367401-ABD080B0-AA02-46B7-AC19-0C5B494DF4E5Q38556737-25DC260E-E702-49A4-9535-E76E5F385609Q42601536-8877F518-36F6-4A17-9B1C-EA217A81FD30Q42718134-BC9B6219-4A43-465E-9A9C-06EE167B334DQ43248670-1D897A10-5C00-4D4D-8B36-0EF7038AB170Q43497034-B5BF5C53-76BE-4CAE-96C8-E3F6450CB482Q45117146-5EB89EC4-D684-4872-9755-D5620F80574DQ46207727-195C38D5-A2BC-4BC0-AB57-8E5968FA56A4Q46505956-5741155C-74D9-41F8-BFCC-E75052543A5DQ46939708-C95F5061-266C-4A16-8EAC-89113A371101Q47890682-95F6F359-8489-402C-A782-57019F5197E1Q48318607-57DAA53F-5931-4A8B-9B3D-A2F27F52DCE3Q49150302-4BA34BE3-7530-4469-BB47-47FB05BCC01A
P2860
Clinically significant drug interactions with antidepressants in the elderly.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinically significant drug interactions with antidepressants in the elderly.
@ast
Clinically significant drug interactions with antidepressants in the elderly.
@en
Clinically significant drug interactions with antidepressants in the elderly.
@nl
type
label
Clinically significant drug interactions with antidepressants in the elderly.
@ast
Clinically significant drug interactions with antidepressants in the elderly.
@en
Clinically significant drug interactions with antidepressants in the elderly.
@nl
prefLabel
Clinically significant drug interactions with antidepressants in the elderly.
@ast
Clinically significant drug interactions with antidepressants in the elderly.
@en
Clinically significant drug interactions with antidepressants in the elderly.
@nl
P1433
P1476
Clinically significant drug interactions with antidepressants in the elderly
@en
P2093
Maria Gabriella Scordo
P304
P356
10.2165/00002512-200219040-00004
P577
2002-01-01T00:00:00Z
P6179
1019639743